About

About

I spent eight years at FDA. I led GMP inspections of small molecules, biologics and combination products, at home and abroad. I now work on the other side of that table, which mostly means asking what an investigator would actually see rather than what a procedure says should be visible.

Portrait of Vioela Respress
Vioela Respress
Quality & Regulatory Consultant

I trained as a chemist. My first work in this industry was analytical: method development, and the slow, specific discipline of knowing what a number means before you act on it. That habit never left, and it turns out to be most of the job.

At FDA I was a lead investigator, running complex GMP inspections across small molecules, biologics and combination products, domestically and overseas. I also spent time evaluating process analytical technology back when investigators covered multiple product areas and had to go deep across all of them. That is why I took chemometrics courses in 2015, because you cannot evaluate what you do not understand.

Since leaving the agency I have worked as a consultant: building quality systems, running mock inspections, preparing sponsors for licence applications, and auditing the contract sites that do the actual manufacturing. I now run my own practice, Respress Solutions, working directly with clients and as an affiliate consultant to specialist GMP consultancies on larger programmes. Most recently that has meant licence-application and pre-license inspection readiness for advanced-therapy products.

What I am actually useful for is the uncomfortable read. I can tell you what an investigator would find, in what order, and how bad it would look, and then help you fix it in the time you have. I would rather give you a hard answer early than a reassuring one that does not survive the first day of an inspection.

Experience

Where I have worked

  1. May 2026–Present

    Principal Consultant

    Respress Solutions LLC · Longwood, FL · Remote

    Independent quality and regulatory practice. I work directly with sponsors and manufacturers, and on contract as an affiliate consultant to Pioneer GMP Consulting on larger programmes.

    • Regulatory and subject-matter lead on licence-application and pre-license inspection readiness for a cell and gene therapy sponsor, covering drug substance, drug product and commercial quality-system readiness.
    • Built CMC deficiency registers and regulatory standards maps tracing every finding to the applicable CFR, ICH and EU GMP requirement.
    • Directed contract-manufacturer audits and site-to-scope responsibility mapping across a multi-site manufacturing network.
    • Published practical frameworks on inspection readiness under the Quality Management System Regulation.
  2. Dec 2024–Mar 2026

    Principal Consultant

    Pioneer GMP Consulting · Remote

    Regulatory and GMP subject-matter lead on CMC-heavy engagements for drug and biologics manufacturers. The relationship continues on a contract basis.

    • Led Annex 1 remediation across sterile manufacturing operations.
    • Designed and delivered mock pre-approval and pre-license inspection programmes, including SME preparation and storyboarding.
    • Spoke at ISPE on inspection readiness.
  3. Oct 2022–Jul 2023

    Principal QA Director / Senior Quality Consultant

    Azzur Group · Remote

    Led quality-system implementation for multiple biotech clients while managing teams of five to ten consultants.

    • Directed mock FDA and EMA audits for pharmaceutical and medical device companies.
    • Established quality systems compliant with QSIT, ISO 13485, MDSAP and GMP requirements.
    • Developed strategic remediation plans for critical quality-system gaps, including Annex 1 assessments for sterile manufacturing.
  4. May 2022–Oct 2022

    Senior Health Scientist

    U.S. Food and Drug Administration · Remote

    Developed strategic quality and compliance plans supporting Office of Regulatory Affairs priorities.

    • Led cross-functional teams on regulatory project implementation.
    • Provided strategic input on FDA guidance documents and managed regulatory communications with industry stakeholders.
  5. Nov 2017–May 2022

    Consumer Safety Officer (Lead Investigator)

    U.S. Food and Drug Administration · Multiple locations

    Led complex GMP inspections across small molecules, biologics and combination products, domestically and abroad.

    • Conducted foreign and domestic inspections assessing compliance with FDA and EU requirements.
    • Developed and implemented remote regulatory assessment programmes during COVID-19.
    • Investigated critical quality issues and compliance concerns, including enforcement follow-up.
  6. Dec 2014–Nov 2017

    Chemist (GMP Inspector & Analyst)

    U.S. Food and Drug Administration · Jamaica, NY

    GMP inspection and analytical work across multiple product areas, before the agency moved to commodity-specific investigator assignments.

    • Evaluated process analytical technology, including near-infrared spectroscopy and multivariate calibration for real-time release.
  7. Apr 2010–Dec 2014

    Scientist (Analytical Chemistry)

    Forest Research Institute · Forest Laboratories · Commack, NY · Dublin, Ireland

    Analytical chemistry and quality work, including a period as Quality Specialist in Dublin.

    • Led corporate-wide quality-system harmonisation during the Forest Laboratories–Actavis merger, integrating more than 500 SOPs.

Capabilities

What I bring

Regulatory & inspections

  • PAI, PLI, for-cause & surveillance inspections
  • 21 CFR 210, 211, 600, 820, 58
  • EU GMP & Annex 1
  • ISO 13485 · QSIT · MDSAP
  • Warning-letter & 483 response

Quality systems

  • Investigations, CAPA & change control
  • Risk-based supplier qualification
  • Data integrity programmes
  • QMS harmonisation across markets
  • Inspection readiness programmes

Technical & platforms

  • Biologics, small molecule & combination products
  • Sterile and advanced-therapy manufacturing
  • Process analytical technology & chemometrics
  • MasterControl · Trackwise · Veeva QMS
  • eCTD · LORENZ docuBridge

Education

  • MSc Chemistry · Long Island University
  • BSc Chemistry · York College, City University of New York

Certifications & training

  • FDA Investigator Certification (Level I & II)
  • EU GMP and Annex 1 Compliance
  • QSIT & MDSAP Lead Auditor
  • Risk-Based Compliance & Data Integrity

Is your site ready for the inspection you are not expecting?

Most of the findings I see were visible months earlier to anyone looking the way an investigator looks. A short conversation is usually enough to tell whether I can help.